Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Multiple Sclerosis Health Center

Font Size

Experimental MS Pill Continues to Show Promise

WebMD Health News
Reviewed by Louise Chang, MD

Sept. 19, 2012 -- An experimental pill is showing promise for the treatment of multiple sclerosis.

In two late-phase studies appearing in The New England Journal of Medicine, the drug BG-12 (dimethyl fumarate) reduced relapses by about half in patients with the most common form of MS.

If approved by the FDA, BG-12, which is being developed by drug maker Biogen Idec, will become the third oral drug for people with multiple sclerosis.

The second -- Sanofi Aventis’ pill Aubagio -- won FDA approval just last week.

“This is an exciting time in the development of new drugs for MS, especially considering the fact that we had no effective treatments just a few decades ago,” says National MS Society Chief Research Officer Timothy Coetzee, PhD.

BG-12 Reduced Relapses, Lesions

Multiple sclerosis is a chronic disease in which the immune system attacks the insulation that coats and protects nerve fibers of the brain and spinal cord.

With the most common type, people experience sporadic attacks or flare-ups of symptoms that are then followed by periods of remission. Symptoms include numbness, fatigue, vision problems, spasms, and issues with bladder and bowel control.

People with this "relapsing-remitting" form of MS were the target group for the new oral drug.

The two newly published trials were funded by the drug’s manufacturer.

In one, patients with relapsing-remitting disease who took BG-12 twice a day had a 44% reduction in relapses over two years of treatment. In the second study, the relapse reduction over the same period was 53%.

The most common side effects associated with treatment were flushing and stomach issues such as diarrhea and abdominal pain. But most patients experienced fewer of these events after the first month of treatment.

Twice-daily treatment was also linked to a 71% reduction in new brain lesions associated with MS in one of the studies, led by neurologist Robert J. Fox, MD, who runs the Cleveland Clinic Mellen Center for Multiple Sclerosis.

Fox has served as a paid Biogen Idec consultant for projects unrelated to the BG-12 study.

“In my opinion, BG-12 offers a very strong combination of (effectiveness), safety, and tolerability,” he says.

Coetzee says it remains to be seen if the new oral drugs will replace standard first-line injectable treatments.

“My guess is that the injectables will remain an important treatment option,” he says. “The more options we have the better.”

That’s because some people do not respond to certain treatments or cannot tolerate them.

Earlier this year, Biogen filed a request with the FDA to market BG-12 in the U.S. A spokeswoman for the company says the agency could rule on the request by the end of the year.

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
woman applying lotion
Ideas on how to boost your mood and self-esteem.
woman pondering
Get personalized treatment options.
man with hand over eye
Be on the lookout for these symptoms.
brain scan
worried woman
neural fiber
white blood cells
sunlight in hands
marijuana plant
muscle spasm